找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Antisense Therapeutics; M. Ian Phillips Book 2005Latest edition Humana Press 2005 RNA.apoptosis.cancer.cancer therapy.cell.drug.drug deliv

[復(fù)制鏈接]
樓主: Weber-test
41#
發(fā)表于 2025-3-28 15:35:33 | 只看該作者
42#
發(fā)表于 2025-3-28 20:11:30 | 只看該作者
Springer Series in Solid-State Sciences (OTS-1) (.). Another unmodified P-ODN was also shown to cross the BBB. This P-ODN was directed at methionine enkephalin (Met-Enk), an opiate peptide associated with alcoholism (unpublished results). The second type of unmodified analog shown to cross the BBB is a peptide nucleic acid (PNA) that was
43#
發(fā)表于 2025-3-28 23:08:06 | 只看該作者
https://doi.org/10.1385/1592598544RNA; apoptosis; cancer; cancer therapy; cell; drug; drug delivery; drug resistance; hepatitis; metabolism; nuc
44#
發(fā)表于 2025-3-29 05:11:14 | 只看該作者
45#
發(fā)表于 2025-3-29 09:42:10 | 只看該作者
Book 2005Latest editionides are being designed and studied in relation to hypertension, various cancers, inflammatory bowel disease, brain disorders, the blood-brain barrier, and drug delivery.Highlights include RNA-based therapies for many diseases, up-to-date methods and applications, and insight into the enormous potential to provide a new generation of drugs.
46#
發(fā)表于 2025-3-29 14:04:12 | 只看該作者
M. Ian PhillipsIncludes supplementary material:
47#
發(fā)表于 2025-3-29 15:41:18 | 只看該作者
Methods in Molecular Medicinehttp://image.papertrans.cn/a/image/158676.jpg
48#
發(fā)表于 2025-3-29 22:21:19 | 只看該作者
49#
發(fā)表于 2025-3-30 02:42:34 | 只看該作者
Springer Series in Solid-State Sciencesition of ribozymes and, more recently, to the inclusion of small interfering RNAs (siRNAs). Antisense therapeutics has also experienced its phases of high expectation, sudden disappointment, and meticulous rediscovery, while maintaining its status as a viable and effective gene therapy approach. Wit
50#
發(fā)表于 2025-3-30 07:28:57 | 只看該作者
Electron Scattering in Solid Matter artery disease (.). PTCA treatment has since become more extensive and gained favor as an alternative treatment for coronary artery bypass grafting (.). The artery is injured at the site of PTCA, leading to wound healing responses including thrombosis, smooth muscle proliferation and migration, ela
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-25 16:00
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
郯城县| 广元市| 咸阳市| 阳泉市| 同仁县| 缙云县| 色达县| 泗阳县| 南昌市| 淅川县| 通海县| 钦州市| 垫江县| 信丰县| 新兴县| 开江县| 临洮县| 泽普县| 渑池县| 延安市| 大庆市| 辽阳市| 莱芜市| 南通市| 海晏县| 凤庆县| 阿拉善右旗| 加查县| 莱州市| 洪洞县| 增城市| 铜山县| 自贡市| 灵台县| 南城县| 麻江县| 镇沅| 建德市| 临海市| 雷山县| 巧家县|